Search

Search Constraints

You searched for: Author/Creator Arlen, Philip M.

Search Results

1. Cabozantinib plus docetaxel and prednisone in metastatic castration‐resistant prostate cancer. (23rd October 2020)

3. Phase II trial of docetaxel, bevacizumab, lenalidomide and prednisone in patients with metastatic castration‐resistant prostate cancer. (19th February 2016)

4. TARP vaccination is associated with slowing in PSA velocity and decreasing tumor growth rates in patients with Stage D0 prostate cancer. (2nd August 2016)